Alterations in Gut Microbiota and Metabolism in Cirrhotic Portal Hypertension: Implications for Disease Progression
Our study reveals that gut microbiota dysbiosis is implicated in CPH progression, potentially providing new avenues for microbiome-based treatment for CPH.
Authors
- Yufei Bi
- Yixin Hou (ORCID: https://orcid.org/0000-0001-8233-7210)
- Jing Yuan (ORCID: https://orcid.org/0000-0002-6939-9676)
- Lina Sun (ORCID: https://orcid.org/0000-0003-1268-7033)
- Qun Zhang (ORCID: https://orcid.org/0000-0003-2208-7998)
- Xiaojing Wang (ORCID: https://orcid.org/0000-0001-6921-3619)
- Hai Li
- Yanqiu Li (ORCID: https://orcid.org/0000-0001-8228-610X)
- Bingbing Zhu
- Xianbo Wang (ORCID: https://orcid.org/0000-0002-3593-5741)
- Lining Guo (ORCID: https://orcid.org/0009-0007-3730-3792)
- Ying Feng (ORCID: https://orcid.org/0009-0001-0822-2754)
- Ke Shi (ORCID: https://orcid.org/0000-0002-8213-3469)
- Guiqin Zhou
- Jinghua Cui (ORCID: https://orcid.org/0000-0001-8427-7784)
- Yi Zhang (ORCID: https://orcid.org/0000-0001-6223-4724)
Institutions
- Shanghai Medical College of Fudan University (CN)
- Shanghai Jiao Tong University (CN)
- Capital Medical University (CN)
- Renji Hospital (CN)
- Capital Institute of Pediatrics (CN)
- Beijing Ditan Hospital (CN)
Publication Details
- Journal
- Alimentary Pharmacology & Therapeutics
- Published
- 2025-10-02
- DOI
- https://doi.org/10.1111/apt.70392
- Citations
- 3
- Primary Topic
- Liver Disease and Transplantation
- Type
- article
- Field-Weighted Citation Impact
- 3.97